Related Experiment Video
Updated: Sep 9, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Resistance to Vip3Aa: A Growing Threat with Unclear Mechanisms and Management Implications
Rajeev Roy1, Dawson Kerns1, Juan Luis Jurat-Fuentes1
1Department of Entomology and Plant Pathology, University of Tennessee, 370 Plant Biotechnology Building, 2505 E. J. Chapman Drive, Knoxville, TN 37996, USA.
Abstract:
The vegetative insecticidal protein Vip3Aa from Bacillus thuringiensis (Bt) has become a key plant-incorporated protectant (PIP) in transgenic crops targeting lepidopteran pests, particularly as resistance increasingly compromises the efficacy of Cry protein PIPs. More than a decade after its commercial deployment, Vip3Aa performance remains efficacious but increasingly vulnerable. Field screens have detected unexpectedly high baseline frequencies of Vip3Aa-resistant alleles and have produced highly resistant strains in several major pests, including Helicoverpa spp., Spodoptera spp., and Mythimna separata. Although structure-function experiments and studies on resistance to Vip3Aa have identified altered midgut processing and impaired receptor binding as candidate resistance mechanisms, the underlying genetic determinants remain poorly understood. Moreover, resistance to Vip3Aa appears to diverge from canonical Cry protein resistance pathways, underscoring the need for dedicated mechanistic studies. This review critically examines the available experimental evidence on Vip3Aa resistance mechanisms, highlighting major knowledge gaps and proposing research priorities to inform resistance monitoring and extend the durability of Vip3Aa-based pest control.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Myocarditis III: Medical Management
Development of Antibiotic Resistance
Endocarditis III: Medical Management
Gene Regulation in Microbial Communities: Quorum Sensing

